HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Design, synthesis, and biological activity of substituted 2-amino-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxylic acid derivatives as inhibitors of the inflammatory kinases TBK1 and IKKε for the treatment of obesity.

Abstract
The non-canonical IκB kinases TANK-binding kinase 1 (TBK1) and inhibitor of nuclear factor kappa-B kinase ε (IKKε) play a key role in insulin-independent pathways that promote energy storage and block adaptive energy expenditure during obesity. Utilizing docking calculations and the x-ray structure of TBK1 bound to amlexanox, an inhibitor of these kinases with modest potency, a series of analogues was synthesized to develop a structure activity relationship (SAR) around the A- and C-rings of the core scaffold. A strategy was developed wherein R7 and R8 A-ring substituents were incorporated late in the synthetic sequence by utilizing palladium-catalyzed cross-coupling reactions on appropriate bromo precursors. Analogues display IC50 values as low as 210 nM and reveal A-ring substituents that enhance selectivity toward either kinase. In cell assays, selected analogues display enhanced phosphorylation of p38 or TBK1 and elicited IL-6 secretion in 3T3-L1 adipocytes better than amlexanox. An analogue bearing a R7 cyclohexyl modification demonstrated robust IL-6 production in 3T3-L1 cells as well as a phosphorylation marker of efficacy and was tested in obese mice where it promoted serum IL-6 response, weight loss, and insulin sensitizing effects comparable to amlexanox. These studies provide impetus to expand the SAR around the amlexanox core toward uncovering analogues with development potential.
AuthorsTyler S Beyett, Xinmin Gan, Shannon M Reilly, Andrew V Gomez, Louise Chang, John J G Tesmer, Alan R Saltiel, Hollis D Showalter
JournalBioorganic & medicinal chemistry (Bioorg Med Chem) Vol. 26 Issue 20 Pg. 5443-5461 (11 01 2018) ISSN: 1464-3391 [Electronic] England
PMID30270002 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
CopyrightCopyright © 2018 Elsevier Ltd. All rights reserved.
Chemical References
  • Anti-Obesity Agents
  • Chromans
  • Protein Kinase Inhibitors
  • Pyridines
  • Protein Serine-Threonine Kinases
  • TBK1 protein, human
  • I-kappa B Kinase
  • IKBKE protein, human
Topics
  • 3T3-L1 Cells
  • Amination
  • Animals
  • Anti-Obesity Agents (chemical synthesis, chemistry, pharmacology, therapeutic use)
  • Chromans (chemical synthesis, chemistry, pharmacology, therapeutic use)
  • Crystallography, X-Ray
  • Drug Design
  • Humans
  • I-kappa B Kinase (antagonists & inhibitors, metabolism)
  • Mice
  • Molecular Docking Simulation
  • Obesity (drug therapy, metabolism)
  • Protein Kinase Inhibitors (chemical synthesis, chemistry, pharmacology, therapeutic use)
  • Protein Serine-Threonine Kinases (antagonists & inhibitors, metabolism)
  • Pyridines (chemical synthesis, chemistry, pharmacology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: